Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combidex MRI for Axillary Node Staging in Breast Cancer
NCT00107484Phase 2Completed
- Sponsor
- Virginia Commonwealth University
- Start
- Sep 2005
- Primary completion
- Oct 2006
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ferumoxtran-10 in breast cancer, sponsored by Virginia Commonwealth University. Primary endpoint: Utility of magnetic resonance imaging using ferumoxtran-10 in identifying metastases to axillary lymph nodes at 2 years. Started Sep 2005; status: completed.
02
Drugs
ferumoxtran-10
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00107484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00107484.